B7-1 (CD80) Mouse Monoclonal Antibody [Clone ID: OTI6H7]
CAT#: TA501668M
Anti-CD80 mouse monoclonal antibody, clone OTI6H7 (formerly 6H7)
Need it in bulk or conjugated? 
                            Get a free quote
                        
CNY 1350.00
货期*
                        现货
                    规格
                        Specifications
| Product Data | |
| Clone Name | OTI6H7 | 
| Applications | FC, IF, WB | 
| Recommend Dilution | WB 1:2000, IF 1:100 | 
| Reactivity | Human | 
| Host | Mouse | 
| Clonality | Monoclonal | 
| Immunogen | Full length human recombinant protein of human CD80 (NP_005182) produced in HEK293T cell. | 
| Isotype | IgG1 | 
| Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. | 
| Concentration | 1 mg/ml | 
| Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) | 
| Conjugation | Unconjugated | 
| Storage Condition | Store at -20°C as received. | 
| Predicted Protein Size | 29.3 kDa | 
| Gene Name | CD80 molecule | 
| Database Link | |
| Background | The B-lymphocyte activation antigen B7-1 (formerly referred to as B7) provides regulatory signals for T lymphocytes as a consequence of binding to the CD28 (MIM 186760) and CTLA4 (MIM 123890) ligands of T cells. [supplied by OMIM] | 
| Synonyms | B7; B7-1; B7.1; BB1; CD28LG; CD28LG1; LAB7 | 
| Reference Data | |
| Protein Families | Druggable Genome, Transcription Factors, Transmembrane | 
| Protein Pathways | Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules (CAMs), Graft-versus-host disease, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Type I diabetes mellitus, Viral myocarditis | 
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 
                         Customer
                                Reviews 
                    
                    
                                Loading...
                            
                        
 
	
 
                         
                             
                             
        